CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC was delisted on the 23rd of June, 2023.
58 hedge funds and large institutions have $29.7M invested in CTI BioPharma Corp. (DE) Common Stock in 2016 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 18 reducing their positions, and 9 closing their positions.
12% more capital invested
Capital invested by funds: $26.7M → $29.7M (+$3.08M)
5% less funds holding
Funds holding: 61 → 58 (-3)
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
33% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$1.09M |
| 2 |
TA
Tiedemann Advisors
New York
|
+$139K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$94.9K |
| 4 |
CG
Caprock Group
Boise,
Idaho
|
+$62.2K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$62.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.6M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$248K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$209K |
| 4 |
Goldman Sachs
New York
|
-$98.5K |
| 5 |
Millennium Management
New York
|
-$97.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Creative Planning
Overland Park,
Kansas
| – | -$34K | -9,174 | Closed |
|
|
TRCT
52
Tower Research Capital (TRC)
New York
| – | -$31K | -8,288 | Closed |
|
|
OAM
53
Oxford Asset Management
Oxford,
United Kingdom
| – | -$19K | -4,944 | Closed |
|
|
CS
54
Credit Suisse
Zurich,
Switzerland
| – | -$16K | -4,419 | Closed |
|
55
Acadian Asset Management
Boston,
Massachusetts
| – | -$8K | -2,161 | Closed |
|
56
Group One Trading
Chicago,
Illinois
| – | -$4K | -1,039 | Closed |
|
57
Commonwealth Equity Services
Waltham,
Massachusetts
| – | -$4K | -1,011 | Closed |
|
58
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| – | -$2K | -544 | Closed |
|
|
FANJ
59
Financial Architects (New Jersey)
Marlton,
New Jersey
| – | -$2K | -510 | Closed |
|
60
Bank of America
Charlotte,
North Carolina
| – | -$917 | -221 | -97% |
|
61
Wells Fargo
San Francisco,
California
| – | +$8 | +2 | +9% |
|
|
IA
62
IFP Advisors
Tampa,
Florida
| – | +$12 | +3 | +3% |
|
CTIC Hedge Fund Activity: Q4 2016 in Review
58 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in CTI BioPharma Corp. (DE) Common Stock (CTIC) for Q4 2016, worth a combined $29.7M — up 12% from $26.7M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of CTIC and 8 opened new positions — a net loss of 1 holder — while 18 trimmed existing stakes and 12 added.
The largest buyer was Stonepine Capital Management, opening a new position worth an estimated $1.09M. The largest seller was Fidelity Investments, cutting an estimated $1.6M.
- 58 institutional investors held CTI BioPharma Corp. (DE) Common Stock (CTIC) as of Q4 2016, down from 61 in Q3 2016.
- Funds reported $29.7M of CTI BioPharma Corp. (DE) Common Stock stock for Q4 2016, up 12% quarter-over-quarter.
- 8 funds opened new CTI BioPharma Corp. (DE) Common Stock positions in Q4 2016 and 9 closed out, a net change of -1 holder.
- The largest CTI BioPharma Corp. (DE) Common Stock buyer in Q4 2016 was Stonepine Capital Management, an estimated $1.09M added.
- The largest CTI BioPharma Corp. (DE) Common Stock seller in Q4 2016 was Fidelity Investments, an estimated $1.6M sold.
Based on aggregated 13F filings for Q4 2016.